Acetazolamid

Acetazolamid
(IUPAC) ime
	N-(5-sulfamoil-1,3,4-tiadiazol-2-il)acetamid
Klinički podaci
Robne marke	Diamoks
AHFS/Drugs.com	Monografija
Identifikatori
CAS broj	59-66-5
ATC kod	S01EC01
PubChem	1986
DrugBank	DB00819
ChemSpider	1909
UNII	O3FX965V0I
KEGG	D00218
ChEBI	CHEBI:27690
ChEMBL	CHEMBL20
Hemijski podaci
Formula	C4H6N4O3S2
Mol. masa	222.245 g/mol
SMILES	eMolekuli & PubHem
InChI
	InChI=1S/C4H6N4O3S2/c1-2(9)6-3-7-8-4(12-3)13(5,10)11/h1H3,(H2,5,10,11)(H,6,7,9) ; Key: BZKPWHYZMXOIDC-UHFFFAOYSA-N
Farmakokinetički podaci
Poluvreme eliminacije	3 do 9 sati
Izlučivanje	Renalno
Farmakoinformacioni podaci
Trudnoća	B3(AU) C(US)
Pravni status	POM (UK) ℞-only (SAD)
Način primene	Oralno, intravenozno

Acetazolamid (Diamoks) je inhibitor karbonske anhidraze koji se koristi za lečenje glaukoma, epoleptičkih napada, idiopatske intrakranijalne hipertenzije, visinske bolesti, cistinurije, i duralne ektazija. On je isto tako diuretik. Acetazolamid je dostupan kao generički lek.^[6]^[7]

Mehanizam dejstva

Acetazolamid je inhibitor karbonske anhidraze. On se koristi u medicini za lečenje umerenih do jakih metaboličkih ili respiratornih alkaloza. On deluje putem ometanja resorpcije bikarbonata (HCO₃^-) u bubrezima, čime povišava kiselost krvi (i alkalnost urina).

Karbonska anhidraza (CA) katalizuje privi deo sledeće reverzibilne reakcije, u kojoj se ugljen dioksid (CO₂) i voda (H₂O) konvertuju do karbonske kiseline (H₂CO₃) i obrnuto:

CO₂ + H₂O <--^CA--> H₂CO₃ <--> H⁺ + HCO₃^-

Reference

↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
↑ Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.
↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit
↑ Hardman JG, Limbird LE, Gilman AG. (2001). Goodman & Gilman's The Pharmacological Basis of Therapeutics (10 izd.). New York: McGraw-Hill. DOI:10.1036/0071422803. ISBN 0-07-135469-7.
↑ Pdr Staff (2009). PDR: Physicians Desk Reference 2010 (Physicians' Desk Reference (Pdr)). Rozelle, N.S.W: Thomson Reuters. ISBN 1-56363-748-0.

Vanjske veze

Diuretici

Šablon:Diuretici

[1] Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit

[2] Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.

[3] Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit

[4] Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.

[5] Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit

[Goodman_Gilman-6] Hardman JG, Limbird LE, Gilman AG. (2001). Goodman & Gilman's The Pharmacological Basis of Therapeutics (10 izd.). New York: McGraw-Hill. DOI:10.1036/0071422803. ISBN 0-07-135469-7.

[PDR-7] Pdr Staff (2009). PDR: Physicians Desk Reference 2010 (Physicians' Desk Reference (Pdr)). Rozelle, N.S.W: Thomson Reuters. ISBN 1-56363-748-0.

[6]

[7]

[1]

[2]

[3]

[4]

[5]